Silk Road Medical, Inc (SILK)
| Market Cap | 1.12B |
| Revenue (ttm) | 191.43M +17.5% |
| Net Income | -56.54M |
| EPS | -1.44 |
| Shares Out | 40.63M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 27.49 |
| Day's Range | 27.49 - 27.49 |
| 52-Week Range | 27.49 - 27.51 |
| Beta | 1.54 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2024 |
About SILK
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid arte... [Read more]
Financial Performance
In 2023, Silk Road Medical's revenue was $177.13 million, an increase of 27.77% compared to the previous year's $138.64 million. Losses were -$55.74 million, 1.33% more than in 2022.
Financial StatementsNews
Boston Scientific Announces Results for Third Quarter 2024
MARLBOROUGH, Mass. , Oct. 23, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.209 billion during the third quarter of 2024, growing 19.4 percent on a reported ...
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
MARLBOROUGH, Mass. , Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: SILK), a medical device c...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY and SILK on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or bre...
SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Silk Road Medica...
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
Studied across thousands of patients and supported by hundreds of clinical publications, the TCAR pioneer has continually delivered positive outcomes through minimally invasive techniques
Boston Scientific Announces Results for Second Quarter 2024
MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent on a reported...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.
NEW YORK , June 18, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Silk Road Medical, Inc. (NASDAQ: SILK) and its board of directors concerning the propos...
Breaking News: Is Silk Road Medical's $27.50 Per Share Sale Price a Fair Deal? Johnson Fistel, LLP Investigates Deal Terms
SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a leading shareholder rights law firm, announced today that it has initiated an investigation into the board members of Silk Road Medi...
Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific.
Boston Scientific will pay $27.50 a share, or $1.16 billion, for Silk Road Medical.
Boston Scientific to buy Silk Road Medical in $1.16 billion deal
Boston Scientific will acquire medical device maker Silk Road Medical in a $1.16 billion deal, the companies said on Tuesday.
Silk Road Medical stock rallies on Boston Scientific acquisition deal
Silk Road Medical Inc.'s stock SILK, +1.31% was up 22.6% in pre-market trades on Tuesday after it agreed to be acquired by Boston Scientific Corp. BSX, -0.74% for $27.50 a share. The deal values the m...
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
Acquisition adds innovative technology for stroke prevention to vascular portfolio MARLBOROUGH, Mass. , June 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has e...
Silk Road Medical Reports First Quarter 2024 Financial Results
SUNNYVALE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resu...
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company w...
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
SUNNYVALE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will repor...
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of...
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has l...
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
SUNNYVALE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul...
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
SUNNYVALE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report...
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi...
Silk Road Medical Reports Third Quarter 2023 Financial Results
SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul...
Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023
SUNNYVALE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report...
Silk Road Medical Stock Sinks. Here's Why Citi Says Sell.
Two pieces of news are weighing on shares of the medical devices company.
Novo Nordisk shares rise, Silk Road Medical stock slumps and other movers
Shares of Thor Industries Inc. THO rose 2% after the RV maker said its board authorized a 7% dividend increase to 48 cents a share.
Silk Road Medical stock falls following outlook, CEO's retirement
Silk Road Medical Inc. SILK, -0.71% shares dropped in the extended session Tuesday after the medical device company updated its forecast and said its chief executive was retiring. The company forecast...